SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

193 hedge funds and large institutions have $571M invested in Sangamo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 28 closing their positions.

Holders
193
Holders Change
–
Holders Change %
0%
% of All Funds
2.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
59
Reduced
59
Closed
28
Calls
$7.57M
Puts
$5.1M
Net Calls
+$2.47M
Net Calls Change
+$276K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$9.78M
2
HighTower Advisors
2
HighTower Advisors
Illinois
$7.14M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$4.16M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$3.63M
5
BlackRock
5
BlackRock
New York
$87.5M

Top Sellers

1
SG Americas Securities
1
SG Americas Securities
New York
$287K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$11.9M
3
Goldman Sachs
3
Goldman Sachs
New York
$9.13M
4
GIM
4
Granahan Investment Management
Massachusetts
$0
5
MIG
5
McGuire Investment Group
Rhode Island
$0
Name Market Value Shares Shares
Change 		Shares
Change %
C
226
Covestor
United Kingdom
$0 46 +46 New
Carson Wealth (CWM LLC)
227
Carson Wealth (CWM LLC)
Nebraska
$0 48 +48 New
6 7 8 9
10